Showing results (71-80 of 202) with videos related to
Sort By:
Pageof 21
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countriesGerald Friedland, Salim Abdool Karim, Quarraisha Abdool Karim, et al.Journal of the International AIDS Society|June 6, 2025
Measuring mobility in HIV research in sub-Saharan Africa: a scoping reviewAleya Khalifa, Sara Wallach, M Kate Grabowski, et al.AIDS Care|October 7, 2014
Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trialStacey M Succop, Kathleen M MacQueen, Francois van Loggerenberg, et al.Journal of the International AIDS Society|April 16, 2026
Impact of Tenofovir Alafenamide Sub-Dermal Implant Insertion Site Scarring on Acceptability and HIV Prevention Preferences: A Prospective Cohort Study in Durban, South AfricaTanuja N Gengiah, Lara Lewis, Ishana Harkoo, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2017
Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel MicrobicideNobubelo K Ngandu, Jonathan M Carlson, Denis R Chopera, et al.AIDS and Behavior|February 23, 2017
Acceptability of Early Antiretroviral Therapy Among South African WomenNigel Garrett, Emily Norman, Kerry Leask, et al.BMC Infectious Diseases|July 24, 2020
Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South AfricaCherise L Naicker, Leila E Mansoor, Halima Dawood, et al.The Journal of Infectious Diseases|July 26, 2012
Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gelVivek Naranbhai, Salim S Abdool Karim, Marcus Altfeld, et al.AIDS and Behavior|March 20, 2014
Monitoring microbicide gel use with real-time notification of the container's opening events: results of the CAPRISA Wisebag studyTanuja N Gengiah, Michele Upfold, Anushka Naidoo, et al.AIDS and Behavior|May 24, 2012
HIV incidence in young girls in KwaZulu-Natal, South Africa--public health imperative for their inclusion in HIV biomedical intervention trialsQuarraisha Abdool Karim, Ayesha B M Kharsany, Janet A Frohlich, et al.Pageof 21